Cancer Research SABCS  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kulbe, H.
Right arrow Articles by Wilson, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kulbe, H.
Right arrow Articles by Wilson, J. L.
[Cancer Research 65, 10355-10362, November 15, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

The Inflammatory Cytokine Tumor Necrosis Factor-{alpha} Regulates Chemokine Receptor Expression on Ovarian Cancer Cells

Hagen Kulbe, Thorsten Hagemann, Piotr W. Szlosarek, Frances R. Balkwill and Julia L. Wilson

Cancer Research UK, Translational Oncology Laboratory, Bart's and The London, Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London, United Kingdom

Requests for reprints: Julia L. Wilson, Cancer Research UK, Translational Oncology Laboratory, Bart's and The London, Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, United Kingdom. Phone: 44-20-7882-5797; Fax: 44-20-7882-6110; E-mail: julia.wilson{at}cancer.org.uk.

Epithelial ovarian cancer cells express the chemokine receptor, CXCR4, which may be associated with increased survival and metastatic potential, but the regulation of this receptor is not understood. The inflammatory cytokine tumor necrosis factor-{alpha} (TNF-{alpha}) is found in ovarian cancer biopsies and is associated with increased tumor grade. In this report, we show that CXCR4 expression on human epithelial ovarian cancer cells is associated with, and can be modulated by, TNF-{alpha}. Ovarian cancer cells with high endogenous expression of TNF-{alpha} expressed higher levels of CXCR4 mRNA and protein than cells with low TNF-{alpha} expression. Stimulation of ovarian cancer cell lines and primary epithelial cancer cells with TNF-{alpha} resulted in increased CXCR4 mRNA and protein. The TNF-{alpha}–stimulated increase in CXCR4 mRNA was due partly to de novo synthesis, and up-regulation of CXCR4 cell surface protein increased migration to the CXCR4 ligand CXCL12. CXCR4 mRNA and protein was down-regulated by anti-TNF-{alpha} antibody or by targeting TNF-{alpha} mRNA using RNAi. TNF-{alpha} stimulation activated components of the nuclear factor {kappa}B pathway, and overexpression of the inhibitor of {kappa}B also reduced CXCR4 expression. Coculture of macrophages with ovarian cancer cells also resulted in cancer cell up-regulation of CXCR4 mRNA in a TNF-{alpha}–dependent manner. Finally, there was a correlation between the levels of TNF-{alpha} and CXCR4 mRNA in clinical biopsies of ovarian cancer, and TNF-{alpha} protein was expressed in CXCR4-positive tumor cells. TNF-{alpha} is a critical mediator of tumor promotion in a number of experimental cancers. Our data suggest that one mechanism may be through nuclear factor {kappa}B–dependent induction of CXCR4.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
J. Kwong, H. Kulbe, D. Wong, P. Chakravarty, and F. Balkwill
An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells
Mol. Cancer Ther., July 1, 2009; 8(7): 1893 - 1905.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-O. Ahn, J.-C. Lee, M.-W. Sung, and D. S. Heo
Presence of Membrane-Bound TGF-{beta}1 and Its Regulation by IL-2-Activated Immune Cell-Derived IFN-{gamma} in Head and Neck Squamous Cell Carcinoma Cell Lines
J. Immunol., May 15, 2009; 182(10): 6114 - 6120.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Wong and W. Korz
Translating an Antagonist of Chemokine Receptor CXCR4: From Bench to Bedside
Clin. Cancer Res., December 15, 2008; 14(24): 7975 - 7980.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Sung, S. Jhurani, K. S. Ahn, Y. Mastuo, T. Yi, S. Guha, M. Liu, and B. B. Aggarwal
Zerumbone Down-regulates Chemokine Receptor CXCR4 Expression Leading to Inhibition of CXCL12-Induced Invasion of Breast and Pancreatic Tumor Cells
Cancer Res., November 1, 2008; 68(21): 8938 - 8944.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Yang, M. Koupenova, D. J. McCrann, K. J. Kopeikina, H. M. Kagan, B. M. Schreiber, and K. Ravid
The A2b adenosine receptor protects against vascular injury
PNAS, January 15, 2008; 105(2): 792 - 796.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
C. Ferretti, L. Bruni, V. Dangles-Marie, A.P. Pecking, and D. Bellet
Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts
Hum. Reprod. Update, March 1, 2007; 13(2): 121 - 141.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Kulbe, R. Thompson, J. L. Wilson, S. Robinson, T. Hagemann, R. Fatah, D. Gould, A. Ayhan, and F. Balkwill
The Inflammatory Cytokine Tumor Necrosis Factor-{alpha} Generates an Autocrine Tumor-Promoting Network in Epithelial Ovarian Cancer Cells
Cancer Res., January 15, 2007; 67(2): 585 - 592.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
B. Sun, J. A. Ranish, A. G. Utleg, J. T. White, X. Yan, B. Lin, and L. Hood
Shotgun Glycopeptide Capture Approach Coupled with Mass Spectrometry for Comprehensive Glycoproteomics
Mol. Cell. Proteomics, January 1, 2007; 6(1): 141 - 149.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.